Skip to main content
. 2017 Aug 14;8(50):87317–87328. doi: 10.18632/oncotarget.20264

Figure 1. Representative immunohistochemical stains in formalin-fixed and paraffin-embedded samples.

Figure 1

Negative control (a), high PD-1 expression (b), PD-L1 (c), and PD-L2 (d) with anti-PD-1 antibody (NAT105, a and b), anti-PD-L1 antibody (ab58810, c), and anti-PD-L2 antibody (MIH18, d). Magnification, ×400.